SCIENTIFIC BACKGROUND

PROS1

Category:

SCIENTIFIC BACKGROUND

Deficiency of active protein S (protein S activity <60%) leads to decreased anticoagulant activity. Protein S is a vitamin K-dependent protein that acts as a cofactor to activated protein C to accelerate the inactivation of coagulation factors Va and VIIIa. Normally, approximately 60% of protein S is present in a complex with the C4b-binding protein, and only free protein S is available as a cofactor for activated protein C. Protein S deficiency is associated with an increased tendency to have venous thrombosis from the 1st to 4th decade of life. Congenital protein S deficiency is classified as follows:

 

  • Type I: quantitative defect, decreased total and free protein S and protein S activity
  • Type II: qualitative defect, decreased protein S activity with a normal concentration of free and total protein S
  • Type III: quantitative defect, decreased free protein S and protein S activity with a normal plasma concentration of total protein S

 

The expression of the clinical phenotype and the age of onset of the disease is influenced by the type and localization of variants in the PROS1 gene. Homozygous or combined heterozygous protein S deficiency is rare and often leads to perinatal purpura fulminans or massive thrombosis with lethal outcomes. Usually, these patients have protein S activity of <5%. It is important to distinguish this from acquired protein S deficiency, which often occurs in association with inflammation, sepsis, burns, polytrauma, vitamin K deficiency, or major surgery. The use of ovulation inhibitors also lowers protein S activity, so in these cases, the lower limit of the normal range for protein S activity is 50%. Molecular genetic testing can detect causative variants in over 60% of patients with suspected congenital protein S deficiency. This corresponds to 1-2% of all patients with deep vein thrombosis. Larger deletions of single exons or more frequently of the entire gene account for approximately 2-5% of all variants. These can be analyzed by MLPA.

 

References

Alhenc-Gelas et al. 2016, Thromb Haemost 115:570 / Klostermeier et al. 2015, Thromb Haemost 113:426 / Duebgen et al. 2012, Am J Clin Pathol 137(2):178 / Pintao et al. 2010, Hum Genet 127:121 / ten Kate et al. 2008, Hum Mutat 29:939 / Yin et al. 2007, Throm Haemost 98:783 / ten Kate et al 2006, Haematologica 91:1151

GENES

PROS1

ASSOCIATED TESTS

How to order

LATEST ARTICLES

Exciting news in genetic research! The Human Pangenome Reference Consortium has unveiled an improved version of the human pangenome reference. This c...

Read more

Duchenne muscular dystrophy, a rare inherited muscle disorder characterized by progressive muscle weakness and degeneration that leads to difficultie...

Read more

May 12 is International Nurses Day. It is celebrated on Florence Nightingale’s birthday. She pioneered the field of modern nursing through her dedi...

Read more

Hair loss is a common problem that affects millions of men and women around the world. While genetics is believed to be the most significant factor c...

Read more

Depression is a serious mental health issue affecting over 280 million people worldwide. Recent research has revealed a potential link between gut he...

Read more

If you are unlucky enough to suffer from migraines, you will know that a migraine is not just a bad headache. The headache and accompanying symptoms ...

Read more

Autism spectrum disorder (ASD) is a neurological developmental disorder that affects brain development and function. This affects how people learn, b...

Read more

Researchers have developed a method called "Mendelian Phenotype Search Engine" (MPSE) to identify which sick infants in the neonatal intensive care u...

Read more

Did you know that wisdom teeth are actually an evolutionary leftover from our ancient ancestors that no longer serve their original purpose? These mo...

Read more

Azoospermia is a medical condition characterized by the absence of sperm in the ejaculate and is a major cause of male infertility. It affects 1 in 1...

Read more